Carberry Christine A. 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Mar 22, 2018
Insider Transaction Report
Form 4
Carberry Christine A.
Chief Operating Officer
Transactions
- Award
Common Stock
2018-03-20+41,250→ 117,202 total - Award
Stock Options (right to buy)
2018-03-20+82,500→ 82,500 totalExercise: $4.16From: 2019-03-20Exp: 2028-03-20→ Common Stock (82,500 underlying)
Footnotes (3)
- [F1]The 41,250 shares are restricted common stock, with one-third of the 41,250 shares vesting on March 20, 2019 and one-twelfth vesting on each of June 20, 2019, September 20, 2019, December 20, 2019, March 20, 2020, June 20, 2020, September 20, 2020, December 20, 2020 and March 20, 2021.
- [F2]Includes 97,916 shares of restricted stock.
- [F3]The stock options vest according to the following schedule: one-third of the 82,500 options will vest on March 20, 2019 and one-twelfth will vest on each of June 20, 2019, September 20, 2019, December 20, 2019, March 20, 2020, June 20, 2020, September 20, 2020, December 20, 2020 and March 20, 2021.